# Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

> **NCT07025785** · NA · RECRUITING · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer
- Lymph Node Metastasis

## Interventions

- **DIAGNOSTIC_TEST:** Circulating tumor DNA

## Key facts

- **NCT ID:** NCT07025785
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-22
- **Primary completion:** 2026-08
- **Final completion:** 2027-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07025785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07025785, "Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07025785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*